2 completed, 2 recruiting. 2 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 2 | Recruiting 2 |
Follow Ibuzatrelvir: new trials by email Literature Review of Ibuzatrelvir trials Research Report on Ibuzatrelvir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Learn How the Study Medicine Called Ibuzatrelvir is Taken up Into the Blood in Healthy Chinese Adults Ibuzatrelvir - Healthy Participant | Phase 1 | Completed | Pfizer | 12 | 2025-10-16 | 2026-01-07 |
| A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised ibuzatrelvir, remdesivir, placebo for ibuzatrelvir - COVID-19 Infection | Phase 3 | Recruiting | Pfizer | 300 | 2025-07-14 | 2026-10-14 |
| A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease ibuzatrelvir, placebo - COVID-19 SARS-CoV-2 Infection | Phase 3 | Recruiting | Pfizer | 2330 | 2024-12-08 | 2026-10-15 |
| A Study to Learn If the Study Medicine Called Carbamazepine Changes How the Body Processes the Other Study Medicine Ibuzatrelvir in Healthy Adults ibuzatrelvir, carbamazepine ER - Healthy | Phase 1 | Completed | Pfizer | 12 | 2024-10-28 | 2025-02-03 |
COVID-19 (3) · Coronavirus Infections (2) · Infections (2) · Lung Diseases (2) · Pneumonia (2) · Pneumonia, Viral (2) · RNA Virus Infections (2) · Respiratory Tract Infections (2) · Virus Diseases (2) · Coronaviridae Infections (1) · Nidovirales Infections (1) · Respiratory Tract Diseases (1)
Pfizer (4)
United States (3) · Argentina (2) · Belgium (2) · Brazil (2) · China (2) · Denmark (2) · Germany (2) · Japan (2) · Mexico (2) · Slovakia (2) · South Korea (2) · Spain (2) · Taiwan (2) · Turkey (Türkiye) (2) · Bulgaria (1)